Hint mode is switched on Switch off
For swift navigation between sections

Alvotech
LEI 222100DCZBOWV5DZ8372

PDF download

Choose all Reset all
Download Cancel
Organization name
Alvotech
Country name
USA
Country of registration
Luxembourg
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
108 mln USD
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Alvotech is a biopharmaceutical company focused on development and manufacturing of high quality biosimilar medicines.

Awards

News

12/11/2025 Alvotech's Upcoming Earnings Report: A Detailed Analysis
24/09/2025 Alvotech (ALVO) Surges 8.6%: Is This an Indication of Further Gains?
All organization news

Documentation

IFRS/US GAAP reports

2025
IV q eng
2024
IV q eng
2023
IV q eng
2022
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Latest issues

Show all

Public debt by currencies

Show more Hide

Codes

  • LEI
    222100DCZBOWV5DZ8372
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001898416
  • EIN
    98-1629342
Registration is required to get access.